China Junshi’s potential COVID-19 drug shows promise in small trial
An antiviral oral drug being co-developed by Shanghai Junshi Biosciences’ subsidiary and other
An antiviral oral drug being co-developed by Shanghai Junshi Biosciences’ subsidiary and other